Cost-minimization analysis of treatment of gastroesophageal reflux disease - Implications of varying holding time on conclusions

Author： Kivioja A. Linnosmaa I. Vehvilainen A. Vohlonen I.

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.21, Iss.2, 2004-02, pp. : 171-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gastroesophageal Reflux Disease in Children with Asthma: Treatment Implications

By Scarupa Mark D.

Pediatric Drugs, Vol. 7, Iss. 3, 2005-01 ,pp. : 177-186

Adis International

Access to resources Recommend Favorite

Treatment of Gastroesophageal Reflux Disease*

By Pettit Michael

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 432-435

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease

By Storr Martin Meining Alexander Allescher Hans-Dieter

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1099-1108

Informa Healthcare

Access to resources Recommend Favorite

New insights into the treatment of gastroesophageal reflux disease

By Campo Salvatore MA

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1503-1515

Informa Healthcare

Access to resources Recommend Favorite

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis

By Escudero-Vilaplana Vicente

International Journal of Clinical Pharmacy, Vol. 35, Iss. 3, 2013-06 ,pp. : 463-468

Springer Publishing Company

Access to resources Recommend Favorite